298 related articles for article (PubMed ID: 21765466)
1. Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer.
Kim K; Chadalapaka G; Lee SO; Yamada D; Sastre-Garau X; Defossez PA; Park YY; Lee JS; Safe S
Oncogene; 2012 Feb; 31(8):1034-44. PubMed ID: 21765466
[TBL] [Abstract][Full Text] [Related]
2. Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.
Kim K; Chadalapaka G; Pathi SS; Jin UH; Lee JS; Park YY; Cho SG; Chintharlapalli S; Safe S
Mol Cancer Ther; 2012 Sep; 11(9):1852-62. PubMed ID: 22752225
[TBL] [Abstract][Full Text] [Related]
3. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.
Gandhy SU; Kim K; Larsen L; Rosengren RJ; Safe S
BMC Cancer; 2012 Nov; 12():564. PubMed ID: 23194063
[TBL] [Abstract][Full Text] [Related]
4. The transcriptional repressor ZBTB4 regulates EZH2 through a MicroRNA-ZBTB4-specificity protein signaling axis.
Yang WS; Chadalapaka G; Cho SG; Lee SO; Jin UH; Jutooru I; Choi K; Leung YK; Ho SM; Safe S; Kim K
Neoplasia; 2014 Dec; 16(12):1059-69. PubMed ID: 25499219
[TBL] [Abstract][Full Text] [Related]
5. miRNA-576-5p promotes endometrial cancer cell growth and metastasis by targeting ZBTB4.
Chen C; Zhang Q; Kong B
Clin Transl Oncol; 2023 Mar; 25(3):706-720. PubMed ID: 36538280
[TBL] [Abstract][Full Text] [Related]
6. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.
Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S
Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812
[TBL] [Abstract][Full Text] [Related]
7. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-Specificity Protein (Sp) Transcription Factor Interactions and Significance in Carcinogenesis.
Safe S
Curr Pharmacol Rep; 2015 Apr; 1(2):73-78. PubMed ID: 26457240
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
Qin H; Liu W
J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
[TBL] [Abstract][Full Text] [Related]
10. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
Mertens-Talcott SU; Chintharlapalli S; Li X; Safe S
Cancer Res; 2007 Nov; 67(22):11001-11. PubMed ID: 18006846
[TBL] [Abstract][Full Text] [Related]
11. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.
Pathi SS; Jutooru I; Chadalapaka G; Sreevalsan S; Anand S; Thatcher GR; Safe S
Mol Cancer Res; 2011 Feb; 9(2):195-202. PubMed ID: 21156786
[TBL] [Abstract][Full Text] [Related]
12. ZNF224, Krüppel like zinc finger protein, induces cell growth and apoptosis-resistance by down-regulation of p21 and p53 via miR-663a.
Cho JG; Park S; Lim CH; Kim HS; Song SY; Roh TY; Sung JH; Suh W; Ham SJ; Lim KH; Park SG
Oncotarget; 2016 May; 7(21):31177-90. PubMed ID: 27105517
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-301b-3p accelerates the growth of gastric cancer cells by targeting zinc finger and BTB domain containing 4.
Fan H; Jin X; Liao C; Qiao L; Zhao W
Pathol Res Pract; 2019 Nov; 215(11):152667. PubMed ID: 31585814
[TBL] [Abstract][Full Text] [Related]
14. Demethylase FTO inhibits the occurrence and development of triple-negative breast cancer by blocking m
Ni J; Lu X; Gao X; Jin C; Mao J
Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):114-128. PubMed ID: 38151999
[TBL] [Abstract][Full Text] [Related]
15. The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.
Sreevalsan S; Safe S
Mol Cancer Ther; 2013 Nov; 12(11):2483-93. PubMed ID: 24030632
[TBL] [Abstract][Full Text] [Related]
16. Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer.
Liu X; Jutooru I; Lei P; Kim K; Lee SO; Brents LK; Prather PL; Safe S
Mol Cancer Ther; 2012 Jul; 11(7):1421-31. PubMed ID: 22553354
[TBL] [Abstract][Full Text] [Related]
17. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression.
Menbari MN; Rahimi K; Ahmadi A; Elyasi A; Darvishi N; Hosseini V; Mohammadi-Yeganeh S; Abdi M
Life Sci; 2019 Nov; 237():116945. PubMed ID: 31605710
[TBL] [Abstract][Full Text] [Related]
18. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
[TBL] [Abstract][Full Text] [Related]
19. The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis.
Noratto GD; Jutooru I; Safe S; Angel-Morales G; Mertens-Talcott SU
Mol Nutr Food Res; 2013 Sep; 57(9):1638-48. PubMed ID: 23471840
[TBL] [Abstract][Full Text] [Related]
20. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
